INSYS Therapeutics Inc.
Rank 142
About
Biotechnology company Insys Therapeutics specialises in cannabinoid research and novel drug delivery systems. Several of their products are in the preclinical stage of development, while SYNDROS and SUBSYS, the company’s flagship solutions, have been approved for patient care. The company’s head office is based in Chandler, Arizona.
$0.3401
USD
-15.00%
Market cap
$25,360,972
Total volume
$2,860,454
Shares outstanding
74,569,163
Rank 142
About
Biotechnology company Insys Therapeutics specialises in cannabinoid research and novel drug delivery systems. Several of their products are in the preclinical stage of development, while SYNDROS and SUBSYS, the company’s flagship solutions, have been approved for patient care. The company’s head office is based in Chandler, Arizona.
Markets
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
INSY |
$2,860,454
|
100% |
$0.3401
|
Chart